Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection.

Tytuł:
Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection.
Autorzy:
Files JK; Division of Infectious Diseases, Department of Medicine, School of Medicine.
Boppana S; Division of Infectious Diseases, Department of Medicine, School of Medicine.
Perez MD; Division of Infectious Diseases, Department of Medicine, School of Medicine.
Sarkar S; Division of Infectious Diseases, Department of Medicine, School of Medicine.
Lowman KE; Division of Infectious Diseases, Department of Medicine, School of Medicine.
Qin K; Division of Infectious Diseases, Department of Medicine, School of Medicine.
Sterrett S; Division of Infectious Diseases, Department of Medicine, School of Medicine.
Carlin E; Division of Infectious Diseases, Department of Medicine, School of Medicine.
Bansal A; Division of Infectious Diseases, Department of Medicine, School of Medicine.
Sabbaj S; Division of Infectious Diseases, Department of Medicine, School of Medicine.
Long DM; Department of Biostatistics, School of Public Health, and.
Kutsch O; Division of Infectious Diseases, Department of Medicine, School of Medicine.; Department of Microbiology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Kobie J; Division of Infectious Diseases, Department of Medicine, School of Medicine.
Goepfert PA; Division of Infectious Diseases, Department of Medicine, School of Medicine.; Department of Microbiology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Erdmann N; Division of Infectious Diseases, Department of Medicine, School of Medicine.
Źródło:
The Journal of clinical investigation [J Clin Invest] 2021 Jan 04; Vol. 131 (1).
Typ publikacji:
Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
Język:
English
Imprint Name(s):
Publication: 1999- : Ann Arbor, MI : American Society for Clinical Investigation
Original Publication: New Haven [etc.] American Society for Clinical Investigation.
MeSH Terms:
Lymphocyte Activation*
Antigens, Differentiation/*immunology
B-Lymphocytes/*immunology
COVID-19/*immunology
SARS-CoV-2/*immunology
T-Lymphocytes/*immunology
Adult ; Aged ; Aged, 80 and over ; B-Lymphocytes/pathology ; COVID-19/pathology ; Female ; Humans ; Male ; Middle Aged ; T-Lymphocytes/pathology
References:
Front Immunol. 2020 Mar 24;11:487. (PMID: 32265932)
Science. 2017 Apr 21;356(6335):. (PMID: 28428369)
Infect Immun. 2004 Aug;72(8):4410-5. (PMID: 15271897)
Nature. 2020 May;581(7809):465-469. (PMID: 32235945)
Lancet Infect Dis. 2013 Sep;13(9):752-61. (PMID: 23891402)
Science. 2020 Sep 4;369(6508):. (PMID: 32669297)
Cell Mol Immunol. 2020 May;17(5):533-535. (PMID: 32203188)
J Infect Dis. 2018 Jan 4;217(2):245-256. (PMID: 29112724)
Lancet. 2020 Feb 15;395(10223):507-513. (PMID: 32007143)
Annu Rev Immunol. 2007;25:443-72. (PMID: 17243893)
J Clin Invest. 2007 Oct;117(10):3029-41. (PMID: 17853940)
J Virol. 2010 Sep;84(18):9318-25. (PMID: 20610717)
Front Immunol. 2019 May 17;10:1116. (PMID: 31156653)
J Clin Invest. 2020 May 1;130(5):2620-2629. (PMID: 32217835)
J Infect Dis. 2020 May 11;221(11):1762-1769. (PMID: 32227123)
N Engl J Med. 2020 Mar 26;382(13):1199-1207. (PMID: 31995857)
Int J Infect Dis. 2020 Apr;93:297-299. (PMID: 32147538)
Nat Med. 2020 Apr;26(4):453-455. (PMID: 32284614)
N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945)
J Immunol. 2009 Aug 1;183(3):2176-82. (PMID: 19592645)
JAMA. 2020 Mar 17;323(11):1061-1069. (PMID: 32031570)
J Virol. 2004 Jun;78(11):5535-45. (PMID: 15140950)
Cell. 2020 Jun 25;181(7):1489-1501.e15. (PMID: 32473127)
N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013)
Vaccine. 2020 Feb 11;38(7):1778-1786. (PMID: 31911030)
JAMA. 2020 May 26;323(20):2052-2059. (PMID: 32320003)
Sci Rep. 2018 Oct 17;8(1):15296. (PMID: 30333570)
Respirology. 2018 Feb;23(2):130-137. (PMID: 29052924)
Immunity. 2016 Jun 21;44(6):1379-91. (PMID: 27287409)
Nat Commun. 2018 Feb 26;9(1):824. (PMID: 29483513)
PLoS One. 2017 Jun 21;12(6):e0179793. (PMID: 28636654)
JCI Insight. 2020 May 21;5(10):. (PMID: 32324595)
Nat Immunol. 2015 Aug;16(8):871-9. (PMID: 26147684)
PLoS One. 2017 Oct 24;12(10):e0186998. (PMID: 29065175)
Int Immunol. 2005 Apr;17(4):383-90. (PMID: 15724062)
BMJ. 2020 Mar 26;368:m1091. (PMID: 32217556)
Front Immunol. 2018 Nov 29;9:2788. (PMID: 30555473)
Nature. 2005 Feb 24;433(7028):887-92. (PMID: 15711573)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Front Immunol. 2020 May 01;11:827. (PMID: 32425950)
Sci Immunol. 2020 Jul 15;5(49):. (PMID: 32669287)
J Exp Med. 2008 Aug 4;205(8):1797-805. (PMID: 18625747)
J Biomed Inform. 2019 Jul;95:103208. (PMID: 31078660)
Emerg Infect Dis. 2017 Jul;23(7):1079-1084. (PMID: 28585916)
Natl Sci Rev. 2020 Jun;7(6):998-1002. (PMID: 34676125)
J Immunol. 2005 Jul 1;175(1):591-8. (PMID: 15972696)
J Exp Med. 2005 Sep 19;202(6):783-91. (PMID: 16157685)
Cell Discov. 2020 May 4;6:31. (PMID: 32377375)
Cell Mol Immunol. 2020 May;17(5):541-543. (PMID: 32203186)
J Autoimmun. 2017 Jul;81:34-43. (PMID: 28343748)
JAMA. 2020 May 12;323(18):1843-1844. (PMID: 32159775)
Immunol Res. 2014 Aug;59(1-3):56-65. (PMID: 24825777)
Immunity. 2020 Jun 16;52(6):971-977.e3. (PMID: 32413330)
Dev Comp Immunol. 1997 Nov-Dec;21(6):471-8. (PMID: 9463780)
Cell Host Microbe. 2020 Jun 10;27(6):879-882.e2. (PMID: 32359396)
PLoS Med. 2005 Dec;2(12):e343. (PMID: 16253012)
Grant Information:
P30 AI027767 United States AI NIAID NIH HHS; K08 AI129705 United States AI NIAID NIH HHS; R56 AI122842 United States AI NIAID NIH HHS; R33 AI133679 United States AI NIAID NIH HHS; R61 AI133679 United States AI NIAID NIH HHS; R33 AI116188 United States AI NIAID NIH HHS; R01 AI122842 United States AI NIAID NIH HHS
Contributed Indexing:
Keywords: COVID-19; Cellular immune response; Immunology
Substance Nomenclature:
0 (Antigens, Differentiation)
Entry Date(s):
Date Created: 20201029 Date Completed: 20210115 Latest Revision: 20240330
Update Code:
20240330
PubMed Central ID:
PMC7773371
DOI:
10.1172/JCI140491
PMID:
33119547
Czasopismo naukowe
SARS-CoV-2 causes a wide spectrum of clinical manifestations and significant mortality. Studies investigating underlying immune characteristics are needed to understand disease pathogenesis and inform vaccine design. In this study, we examined immune cell subsets in hospitalized and nonhospitalized individuals. In hospitalized patients, many adaptive and innate immune cells were decreased in frequency compared with those of healthy and convalescent individuals, with the exception of an increase in B lymphocytes. Our findings show increased frequencies of T cell activation markers (CD69, OX40, HLA-DR, and CD154) in hospitalized patients, with other T cell activation/exhaustion markers (PD-L1 and TIGIT) remaining elevated in hospitalized and nonhospitalized individuals. B cells had a similar pattern of activation/exhaustion, with increased frequency of CD69 and CD95 during hospitalization followed by an increase in PD1 frequencies in nonhospitalized individuals. Interestingly, many of these changes were found to increase over time in nonhospitalized longitudinal samples, suggesting a prolonged period of immune dysregulation after SARS-CoV-2 infection. Changes in T cell activation/exhaustion in nonhospitalized patients were found to positively correlate with age. Severely infected individuals had increased expression of activation and exhaustion markers. These data suggest a prolonged period of immune dysregulation after SARS-CoV-2 infection, highlighting the need for additional studies investigating immune dysregulation in convalescent individuals.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies